Produkty 392274-22-5

CAS 392274-22-5 występuje w naszej ofercie pod nazwami: Oxyresveratrol 2–O–β–D–glucopyranoside, Oxyresveratrol 2-O-β-D-glucopyranoside, ≥95%, ≥95%, Oxyresveratrol 2-O-β-D-glucopyranoside, 99.0%. Oferty producentów: GLPBio, Chemat, MedChemExpress. Dostępne opakowania: 5mg, 20mg, 50mg, 100mg, 5 mg.

Oxyresveratrol 2–O–β–D–glucopyranoside
GLPBio
  • opakowanie: 5mg
  • Warianty: 1
od 1593,99
Zobacz produkt
Oxyresveratrol 2-O-β-D-glucopyranoside, ≥95%, ≥95%
Chemat
  • opakowanie: 20mg, 50mg, 100mg
  • Warianty: 3
od 1984,40
Zobacz produkt
Oxyresveratrol 2-O-β-D-glucopyranoside, 99.0%
MedChemExpress
  • opakowanie: 5 mg
  • Warianty: 1
od 1462,12
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,3R,4S,5S,6R)-2-[2-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-5-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol (CAS 392274-22-5) to związek chemiczny o wzorze sumarycznym C20H22O9 i masie molowej 406.4 g/mol. Nazwa systematyczna IUPAC: (2S,3R,4S,5S,6R)-2-[2-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-5-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol. InChIKey: UPUMEBJDZQEUFC-CUYWLFDKSA-N.

Dane identyfikacyjne
Wzór sumarycznyC20H22O9
Masa molowa406.4 g/mol
Nazwa IUPAC(2S,3R,4S,5S,6R)-2-[2-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-5-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
InChIKeyUPUMEBJDZQEUFC-CUYWLFDKSA-N
SMILESC1=CC(=C(C=C1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)/C=C/C3=CC(=CC(=C3)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Oxyresveratrol 2-O-beta-D-glucopyranoside, Oxyresveratrol 2-O-|A-D-glucopyranoside, orb1684350, orb1940885, Oxyresveratrol 2-O-??-D-glucopyranoside, Oxyresveratrol 2-O-|?-D-glucopyranoside, Oxyresveratrol2-O-beta-D-glucopyranoside, oxyresveratrol-2-O-beta-D-glucopyranoside
Izomery (ten sam wzór sumaryczny)
(3,4,5-trimethoxybenzoyl) 3,4,5-trimethoxybenzoate C20H22O9
(2R,3S,4R,5R)-2-[2,4-dihydroxy-6-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]-3,4,5,6-tetrahydroxyhexanal C20H22O9
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2R)-2-(6-methoxynaphthalen-2-yl)propanoyl]oxyoxane-2-carboxylic acid C20H22O9
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S)-2-(6-methoxynaphthalen-2-yl)propanoyl]oxyoxane-2-carboxylic acid C20H22O9
(2S,3R,4S,5S,6R)-2-[3-[(E)-2-(2,4-dihydroxyphenyl)ethenyl]-5-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C20H22O9
(2S,3R,4S,5S,6R)-2-[3-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-5-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C20H22O9
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-hydroxy-5-[2-(4-hydroxyphenyl)ethyl]phenoxy]oxane-2-carboxylic acid C20H22O9
benzyl 2-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate C20H22O9
(2S,3R,4S,5R)-2-[[(2R,3S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl]oxy]oxane-3,4,5-triol C20H22O9
(2S,3R,4S,5S,6R)-2-[2,4-dihydroxy-6-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C20H22O9
(2S,3R,4S,5S,6R)-2-[5-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]-2-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C20H22O9
(2S,3R,4S,5S,6R)-2-[2,4-dihydroxy-6-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol C20H22O9